“The FDA has announced that Boston Scientific is recalling 48,000 INGENIO pacemakers and cardiac resynchronization therapy pacemakers (CRT-Ps). The recall is due to potential issues when the devices transition to safety mode….”
To read the full article, please click here.
(Shared from Cardiovascular Business, August 6, 2021)